These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25022188)

  • 21. Adderall in the land of Oz.
    Hammerschlag C
    Caring; 2013; 32(2):55. PubMed ID: 23697076
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment with central nervous system stimulants].
    Zlotnik G
    Ugeskr Laeger; 2004 Mar; 166(10):925; author reply 925. PubMed ID: 15045741
    [No Abstract]   [Full Text] [Related]  

  • 23. Differentiating patterns of prescription stimulant medical and nonmedical use among youth 10-18 years of age.
    Wang Y; Cottler LB; Striley CW
    Drug Alcohol Depend; 2015 Dec; 157():83-9. PubMed ID: 26518254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adolescent Patient Education Regarding ADHD Stimulant Diversion And Misuse.
    Colaneri N; Keim S; Adesman A
    Patient Educ Couns; 2017 Feb; 100(2):289-296. PubMed ID: 27609322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological treatment of amphetamine dependence still on unsafe basis].
    Franck J
    Lakartidningen; 2011 Oct 9-15; 108(45):2304-7. PubMed ID: 22242247
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-medical use of prescription stimulants for weight loss, disordered eating, and body image.
    Jeffers AJ; Benotsch EG
    Eat Behav; 2014 Aug; 15(3):414-8. PubMed ID: 25064292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical inquiries. Is methylphenidate useful for treating adolescents with ADHD?
    Mott TF; Leach L; Johnson L
    J Fam Pract; 2004 Aug; 53(8):659-61. PubMed ID: 15298843
    [No Abstract]   [Full Text] [Related]  

  • 28. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
    Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ED visits for nonmedical CNS stimulants rise dramatically: attempts to improve school performance or sexual arousal may drive use.
    Potera C
    Am J Nurs; 2013 Nov; 113(11):14. PubMed ID: 24149250
    [No Abstract]   [Full Text] [Related]  

  • 30. Nonmedical Use of Attention-Deficit/Hyperactivity Disorder Medication Among Secondary School Students in The Netherlands.
    Koster ES; de Haan L; Bouvy ML; Heerdink ER
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):649-52. PubMed ID: 26447641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of attention-deficit/hyperactivity disorder.
    Pierce K
    Pediatr Ann; 2011 Nov; 40(11):556-62. PubMed ID: 22066507
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment with central nervous system stimulants. Practical guidelines].
    Hvolby A; Jørgensen JI
    Ugeskr Laeger; 2004 Jan; 166(3):144-8. PubMed ID: 14870640
    [No Abstract]   [Full Text] [Related]  

  • 34. Substance use disorders in adolescents with attention-deficit/hyperactivity disorder.
    Bukstein O
    Adolesc Med State Art Rev; 2008 Aug; 19(2):242-53, viii. PubMed ID: 18822830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for managing the risks associated with ADHD medications.
    Manning JS
    J Clin Psychiatry; 2013 Sep; 74(9):e19. PubMed ID: 24107770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain gain: the underground world of neuroenhancing drugs.
    Talbot M
    New Yorker; 2009 Apr; ():32-43. PubMed ID: 19399986
    [No Abstract]   [Full Text] [Related]  

  • 37. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulants to enhance academic achievement.
    Stein MT
    J Dev Behav Pediatr; 2012 Sep; 33(7):589. PubMed ID: 22947885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perceived academic benefit is associated with nonmedical prescription stimulant use among college students.
    Arria AM; Geisner IM; Cimini MD; Kilmer JR; Caldeira KM; Barrall AL; Vincent KB; Fossos-Wong N; Yeh JC; Rhew I; Lee CM; Subramaniam GA; Liu D; Larimer ME
    Addict Behav; 2018 Jan; 76():27-33. PubMed ID: 28735038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmedical use of prescription stimulants in the United States.
    Kroutil LA; Van Brunt DL; Herman-Stahl MA; Heller DC; Bray RM; Penne MA
    Drug Alcohol Depend; 2006 Sep; 84(2):135-43. PubMed ID: 16480836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.